Benefits
Antioxidant defense
Selenium is built into about 25 selenoproteins, including glutathione peroxidases and thioredoxin reductases, which help protect cells from oxidative damage. In UK adults with low selenium status, 50 or 100 mcg a day for 15 weeks raised glutathione peroxidase activity in white blood cells. A major review concludes that people whose status is already adequate should not expect benefit from extra selenium.
Thyroid hormone metabolism
Selenoproteins are needed for thyroid hormone metabolism, including production of active thyroid hormone. In women with autoimmune thyroiditis on levothyroxine, 200 mcg a day for 3 months lowered thyroid peroxidase antibodies while TSH, free T4 and free T3 did not change. A 412-patient, 12-month trial also lowered antibodies but did not improve quality of life more than placebo or change levothyroxine dose.
Immune function
Selenoproteins help protect against infection. In 22 UK adults with low selenium, 50 or 100 mcg a day for 15 weeks boosted T cell responses and sped clearance of a live polio vaccine virus. In 117 adults aged 50 to 64 with marginal status, selenium as enriched yeast or onion before flu vaccination had both favourable and unfavourable effects on immune cells. Antibody responses did not change in either trial.
Results of large long-term supplementation trials
In SELECT, 35,533 men took 200 mcg a day of selenomethionine or placebo, and prostate cancer was not reduced (575 cases versus 529). A Cochrane review of trials at low risk of bias found no reduction in overall cancer (risk ratio 1.01), and some trials reported more type 2 diabetes with selenium. This is why extra selenium is not advised for people who already get enough.
Mechanism of action
Selenoprotein synthesis
Selenium is incorporated as selenocysteine into 25 human selenoproteins, which have antioxidant, anti-inflammatory and thyroid hormone functions.
Glutathione peroxidases
Glutathione peroxidases are selenoproteins that help protect cells from oxidative damage. Their activity rose when people with low selenium intake took supplements.
Thioredoxin reductases
Thioredoxin reductases are also selenoproteins. Selenoproteins as a group are involved in DNA synthesis, reproduction and protection from infection.
Clinical trials
Randomized, blinded, placebo-controlled trial of 200 mcg a day sodium selenite or placebo for 3 months in women with autoimmune thyroiditis, all on levothyroxine. Primary outcome: thyroid peroxidase antibody concentration. (Gärtner et al. 2002, J Clin Endocrinol Metab)
70 women (36 selenium, 34 placebo), mean age 47.5, with autoimmune thyroiditis and high thyroid antibodies, all taking levothyroxine.
Mean antibody concentration fell to 63.6 percent of baseline on selenium versus 88 percent on placebo (p = 0.013), and antibodies normalised in 9 selenium patients versus 2 on placebo. TSH, free T4 and free T3 were unchanged in both groups, and thyroglobulin antibodies fell only in the placebo group. An antibody level is a laboratory marker, not a symptom.
Randomized, placebo-controlled trial of 200 mcg a day L-selenomethionine, 400 IU a day vitamin E, both, or placebo, with planned follow-up of 7 to 12 years. Primary outcome: prostate cancer incidence. (Klein et al. 2011, JAMA)
35,533 men in the United States, Canada and Puerto Rico aged 55 or older (50 or older for Black men) with PSA of 4.0 ng/mL or less.
Prostate cancer occurred in 529 men on placebo, 575 on selenium (hazard ratio 1.09, 99% CI 0.93 to 1.27), 620 on vitamin E (hazard ratio 1.17, 99% CI 1.004 to 1.36) and 555 on both. Selenium did not lower prostate cancer risk, and vitamin E raised it.